BioHarvest Sciences (BHST) Competitors $6.20 +0.01 (+0.16%) (As of 12/18/2024 05:26 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsTrends BHST vs. GHRS, AKBA, ESPR, LRMR, CYRX, OLMA, SAGE, CTNM, KMDA, and AQSTShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include GH Research (GHRS), Akebia Therapeutics (AKBA), Esperion Therapeutics (ESPR), Larimar Therapeutics (LRMR), Cryoport (CYRX), Olema Pharmaceuticals (OLMA), Sage Therapeutics (SAGE), Contineum Therapeutics (CTNM), Kamada (KMDA), and Aquestive Therapeutics (AQST). These companies are all part of the "pharmaceutical preparations" industry. BioHarvest Sciences vs. GH Research Akebia Therapeutics Esperion Therapeutics Larimar Therapeutics Cryoport Olema Pharmaceuticals Sage Therapeutics Contineum Therapeutics Kamada Aquestive Therapeutics BioHarvest Sciences (NASDAQ:BHST) and GH Research (NASDAQ:GHRS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Is BHST or GHRS more profitable? GH Research has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -76.65%. BioHarvest Sciences' return on equity of 0.00% beat GH Research's return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-76.65% N/A -85.16% GH Research N/A -20.29%-19.49% Does the media refer more to BHST or GHRS? In the previous week, BioHarvest Sciences had 3 more articles in the media than GH Research. MarketBeat recorded 3 mentions for BioHarvest Sciences and 0 mentions for GH Research. GH Research's average media sentiment score of 1.63 beat BioHarvest Sciences' score of 0.60 indicating that GH Research is being referred to more favorably in the news media. Company Overall Sentiment BioHarvest Sciences Positive GH Research Very Positive Does the MarketBeat Community favor BHST or GHRS? GH Research received 22 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 72.73% of users gave GH Research an outperform vote. CompanyUnderperformOutperformBioHarvest SciencesOutperform Votes2100.00% Underperform VotesNo VotesGH ResearchOutperform Votes2472.73% Underperform Votes927.27% Which has higher valuation & earnings, BHST or GHRS? BioHarvest Sciences has higher revenue and earnings than GH Research. GH Research is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$22.43M4.54-$12.56M-$1.25-4.96GH ResearchN/AN/A-$35.59M-$0.79-9.37 Do analysts recommend BHST or GHRS? BioHarvest Sciences currently has a consensus target price of $13.00, suggesting a potential upside of 109.68%. GH Research has a consensus target price of $35.67, suggesting a potential upside of 381.98%. Given GH Research's higher probable upside, analysts clearly believe GH Research is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00GH Research 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in BHST or GHRS? 56.9% of GH Research shares are held by institutional investors. 41.6% of GH Research shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryGH Research beats BioHarvest Sciences on 9 of the 15 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$101.84M$6.71B$5.03B$8.97BDividend YieldN/A3.07%4.81%4.06%P/E Ratio-4.9610.45133.1816.92Price / Sales4.54187.361,119.91116.20Price / CashN/A57.1640.6337.94Price / Book-5.745.194.754.71Net Income-$12.56M$151.85M$118.34M$225.20M7 Day Performance-3.73%-5.29%11.78%-2.58%1 Month PerformanceN/A-4.63%9.77%3.57%1 Year PerformanceN/A9.45%29.99%16.54% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$6.20+0.2%$13.00+109.7%N/A$101.84M$22.43M-4.96N/AAnalyst ForecastNews CoverageHigh Trading VolumeGHRSGH Research1.8822 of 5 stars$7.70-0.4%$35.67+363.2%+40.7%$400.63MN/A0.0010Positive NewsAKBAAkebia Therapeutics3.4855 of 5 stars$1.83+0.5%$7.50+309.8%+53.0%$399.27M$194.62M0.00167ESPREsperion Therapeutics3.9012 of 5 stars$2.02-20.8%$8.17+304.3%+2.4%$398.02M$116.33M-3.13240Analyst ForecastGap DownHigh Trading VolumeLRMRLarimar Therapeutics1.9228 of 5 stars$6.20+1.5%$20.43+229.5%+0.7%$395.62MN/A-5.3130Analyst ForecastCYRXCryoport3.1206 of 5 stars$7.57-3.4%$12.50+65.1%-49.9%$374.19M$233.26M0.001,170Short Interest ↓Positive NewsOLMAOlema Pharmaceuticals1.8955 of 5 stars$6.30-6.3%$27.00+328.6%-55.1%$360.99MN/A-2.8880Insider TradeGap UpSAGESage Therapeutics4.1579 of 5 stars$5.57-1.8%$12.35+121.8%-76.2%$340.72M$86.46M0.00690Analyst ForecastCTNMContineum Therapeutics1.4626 of 5 stars$13.20-4.3%$29.25+121.6%N/A$340.30M$50M0.0031News CoverageKMDAKamada3.9043 of 5 stars$5.82+0.5%$14.50+149.1%-3.2%$334.53M$142.52M20.68360Positive NewsAQSTAquestive Therapeutics1.447 of 5 stars$3.65-1.1%$9.80+168.5%+80.2%$332.81M$50.58M0.00160Analyst ForecastAnalyst RevisionNews CoveragePositive News Related Companies and Tools Related Companies GH Research Competitors Akebia Therapeutics Competitors Esperion Therapeutics Competitors Larimar Therapeutics Competitors Cryoport Competitors Olema Pharmaceuticals Competitors Sage Therapeutics Competitors Contineum Therapeutics Competitors Kamada Competitors Aquestive Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BHST) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHST Stock Alerts